5 employees
Resvita Bio develops and manufactures engineered probiotics for use in treatment if skin related diseases including cancer.
2021
$250K
from 1 investors over 1 rounds
ResVita Bio raised $250K on September 18, 2023
Investors: National Institute of Allergy and Infectious Diseases (NIAID)